1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. Issue 2 (December 2015) Authors: Papadopoulos, Kyriakos; Tsai, Frank; Hamid, Omid; Xiao, Feng; Steele, Keith; Rebelatto, Marlon; Robbins, Paul; Karakunnel, Joyson; Lai, Dominic; Mahipal, Amit Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies. Issue 1 (22nd August 2019) Authors: Naing, Aung; Infante, Jeffrey; Goel, Sanjay; Burris, Howard; Black, Chelsea; Marshall, Shannon; Achour, Ikbel; Barbee, Susannah; May, Rena; Morehouse, Chris; Pollizzi, Kristen; Song, Xuyang; Steele, Keith; Elgeioushi, Nairouz; Walcott, Farzana; Karakunnel, Joyson; LoRusso, Patricia; Weise, Amy; E... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dermatologists and warts. Issue 6621 (20th February 1988) Authors: Steele, Keith Journal: BMJ Issue: Volume 296:Issue 6621(1988) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. Issue 1 (December 2016) Authors: Rebelatto, Marlon; Midha, Anita; Mistry, Amita; Sabalos, Constantine; Schechter, Nicole; Li, Xia; Jin, Xiaoping; Steele, Keith; Robbins, Paul; Blake-Haskins, John; Walker, Jill Journal: Diagnostic pathology Issue: Volume 11:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of fundholding on removing patients from general practitioners' lists: retrospective study. Issue 7161 (19th September 1998) Authors: O'Reilly, Dermot; Steele, Keith; Merriman, Barry; Gilliland, Andrew; Brown, Scott Journal: BMJ Issue: Volume 317:Issue 7161(1998) Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase Ib/II study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) and tremelimumab as monotherapy or in combination, in patients with recurrent or metastatic gastric/gastroesophageal junction adenocarcinoma. Issue 2 (December 2015) Authors: Kelly, Ronan; Chung, Ki; Gu, Yu; Steele, Keith; Rebelatto, Marlon; Robbins, Paul; Tavakkoli, Fatemeh; Karakunnel, Joyson; Lai, Dominic; Almhanna, Khaldoun Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study. Issue 3 (March 2016) Authors: Antonia, Scott; Goldberg, Sarah B; Balmanoukian, Ani; Chaft, Jamie E; Sanborn, Rachel E; Gupta, Ashok; Narwal, Rajesh; Steele, Keith; Gu, Yu; Karakunnel, Joyson J; Rizvi, Naiyer A Journal: Lancet oncology Issue: Volume 17:Issue 3(2016:Mar.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗